Trends and Key Areas of Research on Artificial Intelligence in Lymphoma: A Bibliometric Study from 2010 to 2024 - Top-Institutions - MDSpire

Trends and Key Areas of Research on Artificial Intelligence in Lymphoma: A Bibliometric Study from 2010 to 2024

  • By

  • Haixin Mao

  • Qin Zhang

  • Dan Wan

  • Yujie Lu

  • Yutao Zhang

  • January 1, 2026

  • 0 min

Share

Top Institutions in Hematology

Brief introduction explaining scope and methodology.

  • #1

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Hematology-Oncology
    • Cancer Genomics
    • Artificial Intelligence in Medicine

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Hematology-Oncology
    • Digital Pathology
    • Machine Learning Applications

  • #3

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Hematology-Oncology
    • Bioinformatics
    • AI in Cancer Imaging

  • #4

    Stanford University School of Medicine
    Stanford University School of Medicine

    Stanford, CA

    Key Differentiators

    • Hematology-Oncology
    • Computational Biology
    • Artificial Intelligence

  • #5

    University of Cambridge
    University of Cambridge

    Cambridge, UK

    Key Differentiators

    • Hematology-Oncology
    • Genomics
    • AI in Medical Research

Original Source(s)

Trends and Key Areas of Research on Artificial Intelligence in Lymphoma: A Bibliometric Study from 2010 to 2024

  • by Haixin Mao, Qin Zhang, Dan Wan, Yujie Lu, Yutao Zhang

  • January 1, 2026

Related Content

Optimisation of patient-reported outcome measurement for haematological cancer patients receiving novel immunotherapies: perspectives of multi-stakeholders

Unexpected Resolution of Stage IV Diffuse Large B-Cell Lymphoma in an HIV-Positive Patient: A Case Study and Review of Existing Literature

Prevalence and Contributing Factors of Hypothyroidism in Hematological Malignancy Patients Compared to Healthy Individuals: A Systematic Review and Meta-Analysis